Sleeping Aid Market to Reach USD 163 Billion by 2032 at 6% CAGR; Pfizer, Merck, Sanofi, GSK Lead
Sleep is a cornerstone of health, yet millions worldwide struggle with sleep disorders like insomnia, sleep apnea, and narcolepsy. The growing prevalence of these conditions, coupled with increasing awareness of sleep’s role in mental and physical well-being, has fueled the expansion of the sleeping aid market. Valued at US$ 29.88 billion in 2024, this market is projected to reach US$...
0 Hozzászólás 0 Megosztás 227 Nézettség